FerGene, launched less than a month ago by Ferring Pharmaceuticals AS and private equity giant Blackstone Life Sciences, has pulled off a coup by poaching David Meek, CEO of Ipsen, to head up the new gene therapy company.
Blow To Ipsen As FerGene Nabs CEO Meek
Bad Timing For French Firm
The new Ferring-backed gene therapy company has bagged a big name player in David Meek as its CEO but the move has created a void at the top for France's Ipsen.
